On April 11, 2016, NanoAntibiotics Inc. entered into and consummated an Agreement and Plan of Merger with LAT Acquisition Corp. and LAT Pharma, LLC. At the effective time of the Merger, board of directors and officers were reconstituted by the appointment of Jonathan Adams as Class III Director, Chairman, Chief Executive Officer, Chief Financial Officer, and Treasurer, Amrit Shahzad as Class II Director, President, and Corporate Secretary, and Cuong Do as Class I Director.

Elliot Ehrlich resigned as Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Chairman and Rajah Menon resigned as President and Director in connection with the Merger. Jonathan Adams, Chief Executive Officer, Chief Financial Officer, and Treasurer, is the founder of LAT Pharma LLC and has served as its CEO since inception in 2006. Amrit Shahzad is a business professional with 25 years of experience in the biopharmaceutical industry.

Prior to starting her own consulting firm in 2014, she worked in variety of leadership roles at Roche, Amgen and Ikaria, and has been on the board of startup companies. She has extensive business and corporate development experience including corporate venture funds. Cuong Do is currently Executive Vice President, Global Strategy Group, Samsung.

Mr. Do helps to set the strategic direction for Samsung Group's diverse business portfolio. He was previously the Chief Strategy Officer for Merck, Tyco Electronics, and Lenovo.